Knight Therapeutics Inc. (KHTRF)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	112.16	80.11	58.76	71.68	85.96	229.59
Short-Term Investments	68.7	92.73	96.61	87.1	63.54	147.32
Trading Asset Securities	-	-	14.5	26.83	10.65	29.15
Cash & Short-Term Investments	180.86	172.84	169.87	185.61	160.16	406.05
Cash Growth	-5.84%	1.75%	-8.48%	15.89%	-60.56%	-1.99%
Accounts Receivable	116.38	105.2	88.72	94.89	55.39	62.52
Other Receivables	9.14	8.34	9.51	13.68	12.03	19.53
Receivables	125.53	113.53	98.23	114	69.96	87.15
Inventory	140.16	102.7	91.83	92.49	72.4	56.51
Prepaid Expenses	7.46	7.74	4.88	3.34	2.17	2.21
Other Current Assets	-	-	0.3	0.18	0.29	0.18
Total Current Assets	454.01	396.81	365.12	395.62	304.97	552.1
Property, Plant & Equipment	20.97	20.02	17.86	22.63	29.94	26.16
Long-Term Investments	87.51	103.43	116.36	152.33	174.23	169.79
Goodwill	90.03	86.48	79.84	82.27	75.4	77.73
Other Intangible Assets	273.05	283.61	289.96	338.78	350.3	156.55
Long-Term Deferred Tax Assets	24.62	21.25	19.39	9.31	2.05	2.43
Other Long-Term Assets	52.86	52.2	53.3	50.13	51.28	51.18
Total Assets	1,003	963.8	945.49	1,055	991.89	1,040
Accounts Payable	117.75	78.35	85.37	106.06	65.31	44.51
Short-Term Debt	-	2.12	0.61	1.61	9.19	10.11
Current Portion of Long-Term Debt	20.66	15.37	17.24	16.06	17.48	41.66
Current Portion of Leases	3.56	2.64	1.73	2.58	1.61	1.88
Current Income Taxes Payable	0.24	0.21	1.18	2.27	7.07	13.56
Other Current Liabilities	10.42	12.56	7.9	12.73	4.64	2.34
Total Current Liabilities	152.61	111.25	114.03	141.32	105.3	114.06
Long-Term Debt	26.33	25.9	44.02	52.4	9.27	-
Long-Term Leases	3.37	3.43	5.5	5.05	3.42	2.54
Long-Term Deferred Tax Liabilities	3.44	3.84	2.82	4.37	12.37	21.62
Other Long-Term Liabilities	21.85	24.27	32.26	25.85	19.52	15.22
Total Liabilities	207.61	168.69	198.62	228.98	149.87	153.44
Common Stock	531.16	534.27	540.05	599.06	628.85	694.35
Additional Paid-In Capital	26.72	25.71	25.99	23.66	21.78	18.73
Retained Earnings	156.81	154.79	150.89	161.76	191.65	174.55
Comprehensive Income & Other	80.75	80.34	29.95	41.38	-0.26	-1.39
Total Common Equity	795.44	795.11	746.87	825.86	842.02	886.24
Shareholders' Equity	795.44	795.11	746.87	825.86	842.02	886.24
Total Liabilities & Equity	1,003	963.8	945.49	1,055	991.89	1,040
Total Debt	53.92	49.46	69.09	77.7	40.96	56.19
Net Cash (Debt)	126.94	123.38	108.18	123.08	119.2	365.18
Net Cash Growth	-2.03%	14.04%	-12.10%	3.26%	-67.36%	-23.76%
Net Cash Per Share	1.25	1.22	1.01	1.07	0.96	2.77
Filing Date Shares Outstanding	99.64	100.05	101.17	110.13	117.03	128.76
Total Common Shares Outstanding	99.64	100.05	101.17	112.21	117.78	130.04
Working Capital	301.39	285.57	251.09	254.3	199.67	438.04
Book Value Per Share	7.98	7.95	7.38	7.36	7.15	6.82
Tangible Book Value	432.36	425.02	377.07	404.8	416.32	651.97
Tangible Book Value Per Share	4.34	4.25	3.73	3.61	3.53	5.01
Land	-	0.01	0.93	1.55	1.09	0.89
Buildings	-	18.5	9.84	14.56	7.69	6.3
Machinery	-	42.56	21.91	33.13	25.94	18.16

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.